Digoxin immune fab: Difference between revisions
No edit summary |
|||
| Line 10: | Line 10: | ||
'''Digoxin Immune Fab (Ovine)''' is the generic name for an antidote for overdose of [[digitalis]].<ref name="pmid11150387">{{cite journal |author=DiDomenico RJ, Walton SM, Sanoski CA, Bauman JL |title=Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity |journal=J. Cardiovasc. Pharmacol. Ther. |volume=5 |issue=2 |pages=77–85 |year=2000 |pmid=11150387 |doi=}}</ref> It is made from immunoglobin fragments from [[sheep]] who have already been immunized with a digoxin derivative, [[digoxindicarboxymethoxylamine]] (DDMA). Its brand names include Digibind and DigiFab, with the former manufactured by [[GlaxoSmithKline]] and the latter manufactured by Protherics, Inc. | '''Digoxin Immune Fab (Ovine)''' is the generic name for an antidote for overdose of [[digitalis]].<ref name="pmid11150387">{{cite journal |author=DiDomenico RJ, Walton SM, Sanoski CA, Bauman JL |title=Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity |journal=J. Cardiovasc. Pharmacol. Ther. |volume=5 |issue=2 |pages=77–85 |year=2000 |pmid=11150387 |doi=}}</ref> It is made from immunoglobin fragments from [[sheep]] who have already been immunized with a digoxin derivative, [[digoxindicarboxymethoxylamine]] (DDMA). Its brand names include Digibind and DigiFab, with the former manufactured by [[GlaxoSmithKline]] and the latter manufactured by Protherics, Inc. | ||
==Category== | ==Category== | ||
[[Digitalis]] antidote. | |||
==FDA Package Insert== | ==FDA Package Insert== | ||
Revision as of 11:12, 27 February 2014
| Digoxin Immune Fab |
|---|
| DIGIFAB® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Digoxin Immune Fab |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
For patient information about Digoxin immune fab, click here.
Synonyms / Brand Names: DIGIFAB ® injection
Overview
Digoxin Immune Fab (Ovine) is the generic name for an antidote for overdose of digitalis.[1] It is made from immunoglobin fragments from sheep who have already been immunized with a digoxin derivative, digoxindicarboxymethoxylamine (DDMA). Its brand names include Digibind and DigiFab, with the former manufactured by GlaxoSmithKline and the latter manufactured by Protherics, Inc.
Category
Digitalis antidote.
FDA Package Insert
DIGIFAB®
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
References
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6832767f-db6b-4eea-b88b-bdfc905749e1